MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Li, Xiao ^a   Lu, Yaer ^a,b   Chen, Yaxia ^a   Lu, Weiguo ^a   Xie, Xing ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Chemoresistance; Formalin fixed paraffin embedded (FFPE); MicroRNA; Ovarian carcinoma

Indexed keywords

FORMALDEHYDE; MICRORNA; MICRORNA 129 5P; MICRORNA 155; MICRORNA 22; MICRORNA 320A; MICRORNA 640; MICRORNA 9; PACLITAXEL; PARAFFIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FORMALIN FIXED PARAFFIN EMBEDDED SAMPLE; FROZEN SECTION; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; SAMPLE; SURVIVAL TIME; UPREGULATION; VALIDATION STUDY;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA; CELL LINE, TUMOR; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PACLITAXEL; RAB GTP-BINDING PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84876806963     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-216     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
2. Kyrgiou M, Salanti G, Pavlidis N, Paraskevaidis E, Ioannidis JP. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. J Natl Cancer Inst 2006, 98:1655-1663. 10.1093/jnci/djj443, 17105988.
3. Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med 2009, 60:167-179. 10.1146/annurev.med.59.053006.104707, 19630570.
4. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 2005, 353:1768-1771. 10.1056/NEJMp058190, 16251533.
5. Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, Liang S, Leminen A, Deng S, Smith L, Johnstone CN, Chen XM, Liu CG, Huang Q, Katsaros D, Calin GA, Weber BL, Bützow R, Croce CM, Coukos G, Zhang L. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 2008, 68:10307-10314. 10.1158/0008-5472.CAN-08-1954, 2762326, 19074899.
6. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008, 68:425-433. 10.1158/0008-5472.CAN-07-2488, 18199536.
7. Eitan R, Kushnir M, Lithwick-Yanai G, David MB, Hoshen M, Glezerman M, Hod M, Sabah G, Rosenwald S, Levavi H. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecol Oncol 2009, 114:253-259.
8. Gillis A, Stoop H, Hersmus R, Oosterhuis JW, Sun Y, Chen C, Guenther S, Sherlock J, Veltman I, Baeten J, van der Spek PJ, de Alarcon P, Looijenga LH. High- throughput microRNAome analysis in human germ cell tumours. J Pathol 2007, 213:319-328. 10.1002/path.2230, 17893849.
9. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, Negrini M. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007, 67:6092-6099. 10.1158/0008-5472.CAN-06-4607, 17616664.
10. Macabeo-Ong M, Ginzinger DG, Dekker N, McMillan A, Regezi JA, Wong DT, Jordan RC. Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses. Mod Pathol 2002, 15:979-987. 10.1097/01.MP.0000026054.62220.FC, 12218216.
11. Bresters D, Schipper ME, Reesink HW, Boeser-Nunnink BD, Cuypers HT. The duration of fixation influences the yield of HCV cDNA-PCR products from formalin-fixed, paraffin-embedded liver tissue. J Virol Methods 1994, 48:267-272. 10.1016/0166-0934(94)90125-2, 7989443.
12. Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, Ju J. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 2007, 13:1668-1674. 10.1261/rna.642907, 1986820, 17698639.
13. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S, Cole CN. Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 2007, 67:11612-11620. 10.1158/0008-5472.CAN-07-5019, 18089790.
14. Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D'Arcy T, McGuinness E, Sheils O, Sheppard B, O'Leary J. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 2008, 7:35. 10.1186/1476-4598-7-35, 2383925, 18442408.
15. Parmar MK, Ledermann JA, Colombo N, du Bois A, Delaloye JF, Kristensen GB, Wheeler S, Swart AM, Qian W, Torri V, Floriani I, Jayson G, Lamont A, Tropé C. ICON and AGO Collaborators. Paclitaxel plus platinum-based chemotherapy versus conventional platinum- based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO -OVAR-2.2 trial. Lancet 2003, 361:2099-2106.
16. Liu S, Kumar SM, Lu H, Liu A, Yang R, Pushparajan A, Guo W, Xu X. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma. J Pathol 2012, 226:61-72. 10.1002/path.2964, 22131135.
17. Helleman J, Jansen MP, Burger C, van der Burg ME, Berns EM. Integrated genomics of chemotherapy resistant ovarian cancer: a role for extracellular matrix, TGF beta and regulating microRNAs. Int J Biochem Cell Biol 2010, 42:25-30. 10.1016/j.biocel.2009.10.016, 19854294.
18. van Jaarsveld MT, Helleman J, Berns EM, Wiemer EA. MicroRNAs in ovarian cancer biology and therapy resistance. Int J Biochem Cell Biol 2010, 42:1282-1290. 10.1016/j.biocel.2010.01.014, 20083225.
19. Sorrentino A, Liu CG, Addario A, Peschle C, Scambia G, Ferlini C. Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol 2008, 111:478-486. 10.1016/j.ygyno.2008.08.017, 18823650.
20. Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, Bentwich I, Einav U, Gilad S, Hurban P, Karov Y, Lobenhofer EK, Sharon E, Shiboleth YM, Shtutman M, Bentwich Z, Einat P. MicroRNA expression detected by oligonucleotide microarrays system establishment and expression profiling in human tissues. Genome Res 2004, 14:2486-2494. 10.1101/gr.2845604, 534673, 15574827.
21. Chen T, Han Y, Yang M, Zhang W, Li N, Wan T, Guo J, Cao X. Rab39, a novel Golgi-associated Rab GTPase from human dendritic cells involved in cellular endocytosis. Biochem Biophys Res Commun 2003, 303:1114-1120. 10.1016/S0006-291X(03)00482-0, 12684051.
22. Luo H, Zhang H, Zhang Z, Zhang X, Ning B, Guo J, Nie N, Liu B, Wu X. Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res 2009, 28:82. 10.1186/1756-9966-28-82, 2739520, 19531230.